Extended ECG Monitoring in HCM Patients

CompletedOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

January 14, 2020

Primary Completion Date

April 18, 2022

Study Completion Date

April 18, 2022

Conditions
Hypertrophic CardiomyopathyNonsustained Ventricular TachycardiaVentricular TachycardiaAtrial FibrillationArrhythmia
Interventions
DEVICE

Zio XT

ambulatory cardiac monitoring device

Trial Locations (1)

02111

Tufts Medical Center, Boston

All Listed Sponsors
lead

iRhythm Technologies, Inc.

INDUSTRY

NCT04056715 - Extended ECG Monitoring in HCM Patients | Biotech Hunter | Biotech Hunter